The pharma stock yields more than 4x the S&P 500 average.
Bristol-Myers Squibb Company (NYSE:BMY) is included among the Best Stocks for a Dividend Stock Portfolio. Bristol-Myers Squibb Company (NYSE:BMY) is a pharmaceutical company focused on developing ...
Bristol Myers Squibb Co. (Symbol: BMY) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a ...
If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to survive.
Bristol Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $17.02B worth of stock held by ETFs, and above-average ''DividendRank'' ...
Bristol-Myers Squibb is attractively valued, offers a 5%+ dividend yield, and benefits from a strong oncology pipeline after its BioNTech deal. The $11B BioNTech partnership gives BMY access to BNT327 ...
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 15 Best Boring Dividend Stocks to Buy. Bayer reported ...
Bristol Myers Squibb is a deep value opportunity, trading at a forward PE of 7x and offering a 5.5% dividend yield. BMY's next-gen portfolio drives double-digit growth, with blockbuster drugs like ...
Fintel reports that on December 4, 2025, Scotiabank maintained coverage of Bristol-Myers Squibb (NYSE:BMY) with a Sector ...
Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 par value common stock of the company.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback